Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01221805 · ClinicalTrials.gov registry record
STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism
A clinical trial, sponsored by Diagnostica Stago.
- Completed
- Registry status
- 2,040
- Enrollment target
NCT01221805 is a clinical trial that has completed, run by Diagnostica Stago. The registered enrollment target is 2,040 participants.
The verdict
NCT01221805 has completed, sponsored by Diagnostica Stago.
- COMPLETED
- Registry status
- 2,040 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,040 participants |
| Start Date | 2011-11 |
| Est. Completion | 2016-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01221805
The ClinicalTrials.gov registry entry for NCT01221805 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,040 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Diagnostica Stago, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01221805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01221805 about?
NCT01221805 is a clinical study titled "STA®-Liatest®D-Di-Exclusion of Venous Thromboembolism". The purpose of this study is to demonstrate the ability of STA® Liatest® D-Di combined with a clinical pretest probability (PTP) to safely exclude pulmonary embolism (PE) or Deep Venous Thrombosis (DVT) in a 3 month follow-up.
What is the current status of trial NCT01221805?
This trial is currently completed. The enrollment target is 2,040 participants. The study started on 2011-11. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT01221805?
This trial is sponsored by Diagnostica Stago, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.